Podcasts

How High Level Information and Hypothesis-Driven Research can Accelerate Industrial Drug Design- Dr Simon Newstead: Dr Simon Newstead explores why uptake transporters are important in drug development, the merits of a structure based analysis, the impact of the recent ITC recommendations and how they will impact research in the next 5 years. listen now

Reflections on the Biomanufacturing Summit and how the Major Topics Apply in the US- Douglas Ball: Douglas Ball, Research Fellow at Pfizer, Inc. reflects on the major issues raised at the Disposable Solutions for Biomanufacturing conference in Belgium such as best manufacturing practice and regulatory guidance and how they apply to Biomanufacturing in the United States. listen now

How Local Knowledge can be Key in Pharmaceutical Logistics- Hubert Koevoets: Ahead of the Pharmaceutical Distribution Conference in Amsterdam, Niamh Madigan interviews Hubert Koevoets, Director Distribution Europe & Transactional Management from Celgene to discover the trials and tribulations of logistics in the pharma industry. listen now

Ensure Manufacturing Readiness: Practical Steps to Prepare for Delegated Acts: Christoph Krahenbuhl, Expert at EFPIA, explains to Pharma IQ the key steps that the Pharmaceutical industry can take to be prepared for the Delegated Acts due to come into force in 2017. listen now

Lundbeck's Ludovic Otterbein on Bottlenecks and Best Practices in Compound Management: "Every company has compound collections of different sizes, but we all face the same challenge of the rising cost of R&D," said Ludovic Otterbein, Head of Global Compound Management and Analytical Chemistry at at H. Lundbeck A/S. listen now

Optimise the Sponsor/Provider Performance; Genzyme Best Practice: Larry Blankstein, Senior Director Clinical Development at Genzyme, looks at optimising the Sponsor/Provider performance by implementing an effective lessons learned process and looks at why partnerships fail and the common causes of those failures. listen now

Addex Therapeutics: Implications of Transporter Regulatory Themes in Drug Development: Sonia Poli, VP for Non Clinical Development at Addex Therapeutics, a small biotech built in Geneva explains how the new FDA and EMA guidelines will impact their business. She looks at the daily challenges they are faced with and stresses the importance of having highly valuated assays which will translate into clinical data. listen now

QbD:Regulatory and Scientific Possibilities and Challenges: Gert Ragnarsson, Director of the Swedish Medical Projects Agency, discusses the biggest milestones in QbD over the last decade, including, the establishment of harmonised guidelines, the formation of the EMA and the recent document published by the FDA, which is a significant step in dealing with advanced formulations. listen now

Public Private Partnerships: A working model for open innovation in Drug Discovery: Dr Wen Hwa Lee, the Strategic Alliances Manager, of the Structural Genomics Consortium (SGC) at University of Oxford, talks to Pharma IQ on benefitting from pre-competitive research and shares insight in a compound discovery case study and the journey involved to bring this into the public domain. listen now

TxCell Biotech's Journey on Implementing a Custom-made Disposable Solution: This podcast is an insight into how challenges were overcome as the small Biotech organisation, TxCell, found a partner to make a customised disposable device to fuilfuill their needs. listen now